Verona Pharma plc
VRNA
$58.92
$0.621.06%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 47.09% | 30.57% | 49.45% | -12.54% | 19.29% |
| Total Receivables | 240.13% | 31.35% | -63.70% | -3.22% | 18.01% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 109.37% | 139.02% | 507.72% | 132.03% | 44.74% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -18.72% | -45.51% | -57.49% | -9.55% | -0.68% |
| Total Current Assets | 56.56% | 31.72% | 44.63% | -11.42% | 19.22% |
|
|
|||||
| Total Current Assets | 56.56% | 31.72% | 44.63% | -11.42% | 19.22% |
| Net Property, Plant & Equipment | 9.82% | 407.54% | 313.38% | 255.92% | 209.71% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 53.91% | 30.55% | 42.84% | -10.28% | 18.75% |
|
|
|||||
| Total Accounts Payable | 222.62% | 730.01% | 66.55% | -35.73% | 20.00% |
| Total Accrued Expenses | 398.10% | 147.56% | 162.89% | -53.29% | -73.93% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 53.14% | 153.19% | 89.17% | 72.00% | 74.81% |
| Total Finance Division Other Current Liabilities | 2,601.38% | 345.91% | 5,200.23% | -21.11% | -74.29% |
| Total Other Current Liabilities | 2,601.38% | 345.91% | 5,200.23% | -21.11% | -74.29% |
| Total Current Liabilities | 391.04% | 210.14% | 341.56% | -44.30% | -54.32% |
|
|
|||||
| Total Current Liabilities | 391.04% | 210.14% | 341.56% | -44.30% | -54.32% |
| Long-Term Debt | 366.70% | 502.91% | 502.74% | 145.07% | 395.23% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -30.08% | 6,645.00% | 4,826.67% | 2,367.69% | 765.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 358.32% | 768.53% | 762.14% | 39.93% | 102.89% |
|
|
|||||
| Common Stock & APIC | 20.10% | 3.34% | 3.38% | 1.99% | 13.01% |
| Retained Earnings | -44.79% | -41.28% | -35.13% | -18.36% | -16.61% |
| Treasury Stock & Other | -2.32% | -1.53% | -4.09% | -1.27% | 0.52% |
| Total Common Equity | -17.94% | -50.48% | -38.38% | -18.70% | 8.16% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -17.94% | -50.48% | -38.38% | -18.70% | 8.16% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -17.94% | -50.48% | -38.38% | -18.70% | 8.16% |
|
|
|||||